The impact of AI on drug discovery innovation
Hosted by Drug Discovery World, this webinar will explore the impact of AI on drug discovery innovation. AI experts and leaders will discuss where innovation is occurring and what the challenges are to overcome in drug discovery and development.
Speakers:
- Martin Brenner, CEO and CSO of iBio
- Raminderpal Singh, Global Head of AI & GenAI Practice, 20/15 Visioneers
- Sid Jain, SVP of Clinical Development & Data Science at Recursion
- Sandy Li, Head of Scientific AI/ML Market Strategy at Benchling
- Jannick Bendtsen, Head of PipeBio at Benchling
You will learn how:
• AI is transforming drug discovery and development
• To navigate the limitations and challenges of implementing AI in R&D
• AI is already being used effectively in real-world drug development research
• Small to mid-size biotechs can also adopt and benefit from AI-driven approaches
PLEASE NOTE: THIS WEBINAR IS OFFERED WITH A CHOICE OF TWO POSSIBLE VIEWING TIMES.
Note: If you are a Benchling customer, be sure to use your work email address. Much of the Benchling Community is only available to customers so this will ensure you receive full access to the platform. Already have an account? Login
Login to the community
No account yet? Create an account
Benchling Employee? Login with SSO
Benchling Employee LoginEnter your E-mail address. We'll send you an e-mail with instructions to reset your password.